What cholesterol-lowering medicines are available besides statins?
Yes. If you cannot take a statin or don’t get enough LDL cholesterol lowering, there are several other medication classes used to lower cholesterol:
Ezetimibe lowers cholesterol absorption in the small intestine and is commonly used when statins are not tolerated or as an add-on to statins.
Bile acid sequestrants (such as cholestyramine/colestipol/colesevelam) bind bile acids in the gut so the liver uses more cholesterol to make new bile acids.
PCSK9 inhibitors are injectable medicines that significantly lower LDL cholesterol and are typically used for people who need more LDL reduction than statins (often including those with familial hypercholesterolemia or very high cardiovascular risk).
Bempedoic acid lowers cholesterol by affecting cholesterol synthesis in the liver and is sometimes used for people who need additional LDL lowering or who can’t take statins.
Inclisiran is an injectable cholesterol-lowering therapy that targets PCSK9 production (used in certain patients who need LDL reduction).
Fibrates can help mainly with high triglycerides (they are not the primary choice for lowering LDL).
Omega-3 fatty acid products (prescription formulations in particular) can lower triglycerides, depending on the formulation and dose.
Niacin (vitamin B3) has historically been used for cholesterol but is used less now because of side effects and limited outcome benefits compared with other options.
Which alternative is best if you’re trying to lower LDL vs triglycerides?
Choice depends on what you want to lower:
If the main goal is lowering LDL cholesterol, ezetimibe, PCSK9 inhibitors, bempedoic acid, bile acid sequestrants, and (in some cases) inclisiran are typical alternatives.
If the main goal is lowering triglycerides, fibrates and prescription omega-3 products are more relevant.
What if you can’t tolerate statins (muscle pain, high liver enzymes)?
For statin intolerance, clinicians often switch to a different statin, use a lower dose, or add a non-statin medication such as ezetimibe or bempedoic acid. People who need larger LDL reductions may use PCSK9 inhibitors or (in selected cases) inclisiran. The best option depends on the reason the statin was stopped and your lipid levels and cardiovascular risk.
Are there combination approaches?
Yes. Common strategies include adding ezetimibe to a statin when LDL reduction is insufficient, or using a non-statin agent when statins are not tolerated. For higher triglycerides, triglyceride-focused drugs (fibrates or prescription omega-3 products) may be used based on your lab results.
What should patients ask about before starting an alternative?
Key questions include:
What cholesterol number are we targeting (LDL vs non-HDL vs triglycerides)?
How much LDL or triglyceride reduction should I expect from this medication?
What side effects should I watch for, and are there interactions with my other prescriptions?
Do I need follow-up blood tests to check response and safety?
Where to look for the most up-to-date drug/patent landscape (if that’s part of your question)
If you’re comparing specific drug options by brand/generic status or checking patent/exclusivity timing, DrugPatentWatch.com tracks patents and related filings and can help you verify what products may be available or constrained by exclusivity. You can search there at DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/